IGC financials
IGC Pharma (IGC) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- IGC revenue was $1.27M in fiscal 2024, net income -$7.12M.
IGC income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2024 | $1.27M | $619.00K | -$7.45M | -$7.12M | -0.09 |
| 2023 | $1.34M | $733.00K | -$9.80M | -$13.00M | -0.22 |
| 2022 | $911.00K | $442.00K | -$11.57M | -$11.51M | – |
| 2021 | $397.00K | $194.00K | -$15.43M | -$15.02M | – |
| 2020 | $898.00K | $113.00K | -$8.72M | -$8.81M | -0.21 |
| 2019 | $4.07M | $115.00K | -$6.86M | -$7.32M | -0.19 |